Thomas Müller
Thomas Müller
Professor of Neurology, Department of Neurology, Head, St Joseph Hospital Berlin Weissensee
Verified email at ruhr-uni-bochum.de - Homepage
Title
Cited by
Cited by
Year
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
R Krüger, W Kuhn, T Müller, D Woitalla, M Graeber, S Kösel, H Przuntek, ...
Nature genetics 18 (2), 106-108, 1998
41261998
Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients
D Blum-Degena, T Müller, W Kuhn, M Gerlach, H Przuntek, P Riederer
Neuroscience letters 202 (1-2), 17-20, 1995
7781995
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
KM Strauss, LM Martins, H Plun-Favreau, FP Marx, S Kautzmann, D Berg, ...
Human molecular genetics 14 (15), 2099-2111, 2005
6072005
Increased susceptibility to sporadic Parkinson's disease by a certain combined α‐synuclein/apolipoprotein E genotype
R Krüger, AM Menezes Vieira‐Saecker, W Kuhn, D Berg, T Müller, ...
Annals of Neurology: Official Journal of the American Neurological …, 1999
3091999
Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double‐blind placebo‐controlled trial
CG Goetz, P Damier, C Hicking, E Laska, T Müller, CW Olanow, O Rascol, ...
Movement disorders: official journal of the Movement Disorder Society 22 (2 …, 2007
2582007
Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease
T Müller, T Büttner, AF Gholipour, W Kuhn
Neuroscience letters 341 (3), 201-204, 2003
2482003
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q10 in Parkinson disease
A Storch, WH Jost, P Vieregge, J Spiegel, W Greulich, J Durner, T Müller, ...
Archives of neurology 64 (7), 938-944, 2007
2452007
Elevated Plasma Levels of Homocysteine inParkinson’s Disease
W Kuhn, R Roebroek, H Blom, D Van Oppenraaij, H Przuntek, ...
European neurology 40 (4), 225-227, 1998
2061998
Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study)
CW Olanow, P Damier, CG Goetz, T Mueller, J Nutt, O Rascol, ...
Clinical neuropharmacology 27 (2), 58-62, 2004
1842004
Short communication Interleukin‐6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease
T Müller, D Blum‐Degen, H Przuntek, W Kuhn
Acta Neurologica Scandinavica 98 (2), 142-144, 1998
1831998
Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients
P Wintermeyer, R Krüger, W Kuhn, T Müller, D Woitalla, D Berg, G Becker, ...
Neuroreport 11 (10), 2079-2082, 2000
1652000
Novel homozygous p. E64D mutation in DJ1 in early onset Parkinson disease (PARK7)
R Hering, KM Strauss, X Tao, A Bauer, D Woitalla, EM Mietz, S Petrovic, ...
Human mutation 24 (4), 321-329, 2004
1612004
Nigral endothelial dysfunction, homocysteine, and Parkinson's disease
T Muller, B Weme, B Fowler, W Kuhn
The Lancet 354 (9173), 126-127, 1999
1551999
Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers
R Krüger, W Kuhn, KL Leenders, R Sprengelmeyer, T Müller, D Woitalla, ...
Neurology 56 (10), 1355-1362, 2001
1442001
Diagnostic staging of Parkinson’s disease: conceptual aspects
H Przuntek, T Müller, P Riederer
Journal of neural transmission 111 (2), 201-216, 2004
1412004
Predictors of gastric emptying in Parkinson's disease
O Goetze, AB Nikodem, J Wiezcorek, M Banasch, H Przuntek, T Mueller, ...
Neurogastroenterology & Motility 18 (5), 369-375, 2006
1332006
5-HT1A receptor-effector system responsivity in panic disorder
KP Lesch, M Wiesmann, A Hoh, T Müller, J Disselkamp-Tietze, ...
Psychopharmacology 106 (1), 111-117, 1992
1271992
Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients
T Müller, C Erdmann, D Bremen, WE Schmidt, S Muhlack, D Woitalla, ...
Clinical neuropharmacology 29 (2), 61-67, 2006
1252006
Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder
KP Lesch, A Hoh, HM Schulte, M Osterheider, T Müller
Psychopharmacology 105 (3), 415-420, 1991
1251991
Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breath test
O Goetze, J Wieczorek, T Mueller, H Przuntek, WE Schmidt, D Woitalla
Neuroscience letters 375 (3), 170-173, 2005
1182005
The system can't perform the operation now. Try again later.
Articles 1–20